Lymphedema prevalence and treatment benefits in cancer: Impact of a therapeutic intervention on health outcomes and costs

PLoS ONE

Volumn 9, Issue 12, 2014, Pages

  Brayton, Kimberly M ^a   Hirsch, Alan T ^b   O'Brien, Patricia J ^c   Cheville, Andrea ^d   Karaca Mandic, Pinar ^e   Rockson, Stanley G ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF VERMONT   (United States)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVOR; CELLULITIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTPATIENT CARE; PHYSIOTHERAPY; PREVALENCE; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT; ECONOMICS; NEOPLASMS; PATHOLOGY;

ADULT; AGED; FEMALE; HEALTH CARE COSTS; HUMANS; INSURANCE, HEALTH; INTERMITTENT PNEUMATIC COMPRESSION DEVICES; LYMPHEDEMA; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84946862586     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0114597     Document Type: Article

References (28)

1. Szuba A, Shin WS, Strauss HW, Rockson S (2003) The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 44: 43-57.
2. Radhakrishnan K, Rockson SG (2008) The clinical spectrum of lymphatic disease. Ann N Y Acad Sci. 1131: 155-184.
3. Paskett ED, Naughton MJ, McCoy TP, Case LD, Abbott JM (2007) The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 16: 775-782.
4. Williams AF, Franks PJ, Moffatt CJ (2005) Lymphoedema: estimating the size of the problem. Palliat Med. 19: 300-313.
5. McWayne J, Heiney SP (2005) Psychologic and social sequelae of secondary lymphedema: A review. Cancer. 104: 457-466.
6. Ridner SH (2009) The psycho-social impact of lymphedema. Lymphat Res Biol. 7: 109-112.
7. Rockson SG (2010) Current concepts and future directions in the diagnosis and management of lymphatic vascular disease. Vasc Med. 15: 223-231.
8. Mondry TE, Riffenburgh RH, Johnstone PA (2004) Prospective trial of complete decongestive therapy for upper extremity lymphedema after breast cancer therapy. Cancer J. 10: 42-48; discussion 17-49.
9. Lawenda BD, Mondry TE, Johnstone PA (2009) Lymphedema: A primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 59: 8-24.
10. Moffatt CJ, Franks PJ, Doherty DC, Williams AF, Badger C, et al. (2003) Lymphoedema: A n underestimated health problem. Qjm. 96: 731-738.
11. Schmitz KH, Ahmed RL, Troxel A, Cheville A, Smith R, et al. (2009) Weight lifting in women with breast-cancer-related lymphedema. N Engl J Med. 361: 664-673.
12. McKenzie DC, Kalda AL (2003) Effect of upper extremity exercise on secondary lymphedema in breast cancer patients: A pilot study. J Clin Oncol. 21: 463-466.
13. Ahmed RL, ThomasW, Yee D, Schmitz KH (2006) Randomized Controlled Trial of Weight Training and Lymphedema in Breast Cancer Survivors. J Clin Oncol. 24: 2765-72.
14. Badger CM, Peacock JL, Mortimer PS (2000) A randomized, controlled, parallel-group clinical trial comparing multilayer bandaging followed by hosiery versus hosiery alone in the treatment of patients with lymphedema of the limb. Cancer. 88: 2832-2837.
15. Chang CJ, Cormier JN (2013) Lymphedema interventions: exercise, surgery, and compression devices. Semin Oncol Nurs. 29: 28-40.
16. Rockson SG (2008) Diagnosis and management of lymphatic vascular disease. J Am Coll Cardiol. 52: 799-806.
17. Rockson SG (2001) Lymphedema. Am J Med. 110: 288-295.
18. Szuba A, Achalu R, Rockson SG (2002) Decongestive lymphatic therapy for patients with breast carcinoma-associated lymphedema. A randomized, prospective study of a role for adjunctive intermittent pneumatic compression. Cancer. 95: 2260-2267.
19. Muluk SC, Hirsch AT, Taffe EC (2013) Pneumatic compression device treatment of lower extremity lymphedema elicits improved limb volume and patient-reported outcomes. Eur J Vasc Endovasc Surg. 46: 480-487.
20. Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, et al. (2009) Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: A 2-year follow-up study. J Clin Oncol. 27: 2007-2014.
21. Hirsch AT, Hartman L, Town RJ, Virnig BA (2008) National health care costs of peripheral arterial disease in the Medicare population. Vasc Med. 13: 209-215.
22. Margolis J, Barron JJ, Grochulski WD (2005) Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data. J Manag Care Pharm. 11: 727-734.
23. Snyder JJ, Kasiske BL, Maclean R (2006) Peripheral arterial disease and renal transplantation. J Am Soc Nephrol. 17: 2056-2068.
24. Cull DL, Langan EM, Gray BH, Johnson B, Taylor SM (2010) Open versus endovascular intervention for critical limb ischemia: A population-based study. J Am Coll Surg. 210: 555-561, 561-553.
25. Eslami MH, Zayaruzny M, Fitzgerald GA (2007) The adverse effects of race, insurance status, and low income on the rate of amputation in patients presenting with lower extremity ischemia. J Vasc Surg. 45: 55-59.
26. Hillner BE, Mandelblatt J (2006) Caring for older women with breast cancer: can observational research fill the clinical trial gap? J Natl Cancer Inst. 98: 660-661.
27. Stout NL, Weiss R, Feldman JL, Stewart BR, Armer JM, et al. (2013) A systematic review of care delivery models and economic analyses in lymphedema: health policy impact (2004-2011). Lymphology. 46: 27-41.
28. Current Population Survey (2012, 2013) Uninsured UIaKCoMat. Health Insurance Coverage of the Total Population. 2012, 2013: Estimates based on the Census Bureau's March 2012 and 3 Current Population Survey (CPS: A nnual Social and Economic Supplements).